Medicare Enrolled
Dr. Nam Do, M.D.
Internal Medicine · Amarillo, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Do from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Do? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Do
Dr. Nam Do is an internal medicine in Amarillo, TX, with 19 years in practice. Based on federal Medicare data, Dr. Do performed 24,585 Medicare services across 12,044 unique beneficiaries.
Between the years covered by Open Payments, Dr. Do received a total of $8,892 from 40 pharmaceutical and/or device companies across 594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Do is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in TX$ $8,892 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,585
Medicare services
Top 2% in TX for internal medicine
12,044
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,294 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 2,506 | $46 | $63 |
| Blood draw (venipuncture) | 2,072 | $5 | $6 |
| Office visit, established patient (30-39 min) | 2,030 | $86 | $140 |
| Comprehensive metabolic blood panel | 1,811 | $10 | $15 |
| Lipid panel (cholesterol and triglycerides) | 1,760 | $13 | $21 |
| Ldl cholesterol level | 1,753 | $10 | $14 |
| Complete blood count (CBC) with differential | 953 | $7 | $11 |
| Office visit, established patient (20-29 min) | 931 | $63 | $96 |
| Hemoglobin A1c test (diabetes monitoring) | 737 | $9 | $14 |
| Urinalysis with microscopic exam | 690 | $3 | $5 |
| Thyroid stimulating hormone (TSH) test | 603 | $16 | $25 |
| Free thyroxine (T4) test | 573 | $9 | $14 |
| Vitamin B-12 level test | 542 | $15 | $23 |
| Vitamin D level test | 466 | $29 | $39 |
| Advance care planning consultation, first 30 min | 429 | $57 | $86 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 427 | $25 | $26 |
| Annual wellness visit, follow-up | 417 | $112 | $115 |
| Basic metabolic blood panel | 376 | $8 | $14 |
| Annual depression screening | 319 | $17 | $18 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 294 | $1 | $15 |
| Creatine kinase (cardiac enzyme) level, total | 284 | $6 | $19 |
| Chronic care management, additional 20 min/month | 271 | $36 | $49 |
| Flu vaccine administration | 270 | $24 | $25 |
| Steroid injection (triamcinolone) | 250 | $1 | $25 |
| Flu vaccine, high-dose | 231 | $67 | $72 |
| Electrocardiogram (EKG), 12-lead | 199 | $10 | $20 |
| Drug injection, under skin or into muscle | 197 | $10 | $16 |
| Liver function blood test panel | 181 | $8 | $21 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 176 | $24 | $42 |
| Folic acid level test | 158 | $14 | $21 |
| Removal of impacted ear wax | 152 | $32 | $49 |
| Uric acid level test | 143 | $4 | $7 |
| Ferritin level test (iron stores) | 135 | $13 | $53 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 129 | $34 | $51 |
| Iron level test | 119 | $6 | $28 |
| Iron binding capacity test | 107 | $8 | $14 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 104 | $67 | $100 |
| Stool analysis for blood to screen for colon tumors | 96 | $4 | $15 |
| Chest X-ray, 2 views | 87 | $17 | $29 |
| Pneumonia vaccine administration | 86 | $29 | $30 |
| Bone density scan (DEXA) | 77 | $36 | $44 |
| Urine microalbumin (protein) analysis | 72 | $6 | $7 |
| Bilirubin level, direct | 62 | $5 | $7 |
| Magnesium level test | 62 | $7 | $20 |
| Sed rate test (inflammation marker) | 56 | $3 | $4 |
| Pneumococcal vaccine, 23-valent | 55 | $128 | $175 |
| Transitional care management services for problem of high complexity | 50 | $189 | $244 |
| Cortisol (hormone) measurement, total | 45 | $16 | $65 |
| Destruction of precancerous skin growths, 2-14 | 44 | $4 | $5 |
| Testosterone (hormone) level, total | 42 | $25 | $38 |
| Creatinine test (kidney function) | 41 | $5 | $8 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 41 | $140 | $152 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 37 | $280 | $450 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 37 | $19 | $60 |
| Test to determine lung volumes using sensors | 37 | $29 | $52 |
| Test to examine how well the lungs exchange gases | 37 | $32 | $54 |
| Destruction of precancerous skin growth, 1 | 35 | $43 | $66 |
| X-ray of upper spine, 2-3 views | 31 | $19 | $30 |
| Amylase (enzyme) level | 29 | $6 | $10 |
| Hepatitis c antibody measurement | 29 | $14 | $60 |
| X-ray of lower and sacral spine, 2-3 views | 28 | $21 | $33 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 28 | $22 | $40 |
| Prostate cancer screening; prostate specific antigen test (psa) | 27 | $19 | $69 |
| Injection, ketorolac tromethamine, per 15 mg | 27 | $0 | $15 |
| COVID-19 vaccine administration | 26 | $39 | $46 |
| COVID-19 vaccine (Moderna bivalent) | 26 | $143 | $151 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 26 | $14 | $15 |
| Analysis for antibody to helicobacter pylori (gastrointestinal bacteria) | 25 | $17 | $78 |
| Echocardiogram, transthoracic | 24 | $92 | $127 |
| Natriuretic peptide (heart and blood vessel protein) level | 23 | $38 | $89 |
| Parathyroid hormone level test | 22 | $40 | $150 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 22 | $36 | $55 |
| Joint injection, major joint | 20 | $44 | $63 |
| Shoulder X-ray, 2+ views | 20 | $18 | $26 |
| Adm sarscv2 bvl 50mcg/.5ml a | 19 | $39 | $40 |
| Retinal photography (fundus photo) | 19 | $11 | $41 |
| X-ray of paranasal sinus, 1-2 views | 18 | $16 | $26 |
| Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | 18 | $57 | $400 |
| Limited ultrasound scan of abdomen | 16 | $37 | $69 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 16 | $156 | $170 |
| Hip X-ray, 2-3 views | 15 | $26 | $37 |
| Complete ultrasound scan behind abdominal cavity | 15 | $56 | $83 |
| New patient office visit (45-59 min) | 15 | $101 | $192 |
| Ultrasound scan of head and neck soft tissue | 14 | $59 | $88 |
| PSA test (prostate cancer screening) | 14 | $18 | $31 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 14 | $113 | $153 |
| Transitional care management services for problem of at least moderate complexity | 14 | $145 | $185 |
| Creatinine clearance measurement to test for kidney function | 13 | $9 | $19 |
| Total protein level, urine | 13 | $3 | $42 |
| Screening test for autoimmune disorder | 13 | $12 | $16 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 12 | $31 | $46 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
3.4% medium
96.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,892
Total received (2018-2024)
Avg $1,270/year across 7 years
Top 10% in TX for internal medicine
40
Companies
594
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,528 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$364 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,422
2023$1,006
2022$135
2021$12
2020$294
2019$2,527
2018$2,496
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,143
Boehringer Ingelheim Pharmaceuticals, Inc.
$906
Novo Nordisk Inc
$773
Lilly USA, LLC
$710
Astellas Pharma US Inc
$680
GlaxoSmithKline, LLC.
$607
PFIZER INC.
$606
E.R. Squibb & Sons, L.L.C.
$488
Amgen Inc.
$390
Janssen Pharmaceuticals, Inc
$364
Takeda Pharmaceuticals U.S.A., Inc.
$294
ABBVIE INC.
$263
Amarin Pharma Inc.
$200
Novartis Pharmaceuticals Corporation
$191
Phathom Pharmaceuticals, Inc.
$159
AbbVie Inc.
$158
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$139
SANOFI-AVENTIS U.S. LLC
$126
Orexigen Therapeutics, Inc.
$94
AbbVie, Inc.
$67
Dexcom, Inc.
$57
Allergan Inc.
$45
Lundbeck LLC
$38
Merck Sharp & Dohme Corporation
$36
Teva Pharmaceuticals USA, Inc.
$34
Daiichi Sankyo Inc.
$33
Kowa Pharmaceuticals America, Inc.
$33
Genentech USA, Inc.
$32
IDORSIA PHARMACEUTICALS US INC
$30
Antares Pharma, Inc.
$29
Merck Sharp & Dohme LLC
$28
Abbott Laboratories
$20
Supernus Pharmaceuticals, Inc.
$19
Medtronic, Inc.
$18
Nalpropion Pharmaceuticals, Inc.
$16
Neurocrine Biosciences, Inc.
$15
Mylan Specialty L.P.
$14
Otsuka America Pharmaceutical, Inc.
$12
Biohaven Pharmaceutical Holding Company Ltd.
$12
Synergy Pharmaceuticals Inc
$12
Top 3 companies account for 31.7% of total payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · AJOVY · ANORO · Aimovig · Amitiza · Androgel · Austedo XR · BASAGLAR · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BYDUREON · BYSTOLIC · CAMZYOS · CHANTIX · CONTRAVE · CREON · Creon · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · INGREZZA · INJECTAFER · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Movantik · Myrbetriq · NURTEC ODT · OTREXUP · OXTELLAR XR · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · Perforomist · Prolia · QULIPTA · QUVIVIQ · REXULTI · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · Uloric · VESICARE · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for internal medicine in TX.
Equivalent to $36 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
104
Per 100K population
89.2
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Do is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Do experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Do performed 2,506 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Do receive payments from pharmaceutical companies?
Yes. Dr. Do received a total of $8,892 from 40 companies across 594 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Do's costs compare to other internal medicines in Amarillo?
Dr. Do's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Do) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Amarillo
Browse internal medicines in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in TX
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in TX
Which TX internal medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology